Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on July 1, 2026

Jul. 1, 2026

Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Indeterminate GlobeNewswire

Jul. 1, 2026

Correction: Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares

Indeterminate GlobeNewswire

Jul. 1, 2026

FORMULA 1® AND FLEXJET ANNOUNCE MULTI-YEAR GLOBAL PARTNERSHIP

Indeterminate GlobeNewswire

Jul. 1, 2026

Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29

Indeterminate GlobeNewswire

Jul. 1, 2026

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Indeterminate GlobeNewswire

Jul. 1, 2026

Medline to report second quarter 2026 results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 1, 2026

LiveWorld Names Rob Thomas Vice President, Creative Director to Support Growing Healthcare Creative Practice

Indeterminate GlobeNewswire

Jul. 1, 2026

JenaValve Recaps Key Highlights Including Late-Breaking Clinical Data from New York Valves 2026

Indeterminate GlobeNewswire

Jul. 1, 2026

Creative Medical Technology Holdings Issues Mid-Year Update

Indeterminate GlobeNewswire

Jul. 1, 2026

Cyabra Recognized as a Market Shaper in the Inaugural June 2026 Gartner® Emerging Market Quadrant for Narrative Intelligence— Startup Vendors, as AI-Driven Manipulation Reshapes Digital Trust

Indeterminate GlobeNewswire

Jul. 1, 2026

Rethink Food and Just Salad Roll Out Rethink Food Bowl for July

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba has received marketing authorization in France for its biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Learning Care Brings the FIFA World Cup 2026™ to Thousands of Young Children Nationwide with Soccer Shots’ Global Goals Program

Indeterminate GlobeNewswire